Cannabis flower sold in Colorado claims to contain much more tetrahydrocannabinol, or THC, than it actually does, according to my findings published in the peer-reviewed journal Plos One.
Why it matters
Accurate THC reporting is a linchpin for medical patients, recreational consumers and the overall integrity of the cannabis industry. Medical and recreational flower is generally the same—the difference is in testing requirements, price, taxes and purchase limits. Misleading potency information can disrupt medical dosages, misguide recreational users and erode trust in an industry striving for legitimacy.
Consumers often associate higher THC levels in cannabis flower with superior quality, potentially leading to overpayment for products that may not meet their expectations. This misconception can also create incentives for cultivators, testing labs and dispensaries to generate higher THC numbers—whether through cultivation techniques or through testing fraud.
Additionally, testing for toxins, pesticides and total yeast and mold can also fall victim to falsification. Recent reports reveal instances where labs in New York and other states have passed products that should have failed. This casts doubt on the credibility of the broader testing processes in place.
How I did my work
I gathered a total of 23 cannabis flower samples from 10 dispensaries across the northern Colorado Front Range, which includes Denver, Fort Collins and Garden City. The samples encompassed 12 strains, including indica, sativa and hybrid types, and varied in reported THC values. Some had ranges, such as 12.8 percent to 19.3 percent on the lower end and 28.07 percent to 31.28 percent on the higher end, while others had single values, such as 16.4 percent or 17.4 percent.
I sent the samples to a third-party testing lab that does high-performance liquid chromatography, or HPLC. HPLC is a method to separate, identify and quantify components in mixtures based on their chemical properties. It is the most commonly used method in cannabis testing to analyze cannabinoids and detect contaminants. This can ensure product potency, safety and quality.
Approximately 70 percent of the labels reported THC percentages more than 15 percent higher than what was quantified through the lab.
Among the 23 flower samples analyzed, 18 displayed lower THC levels than reported—with 16 falling below 15 percent of the stated value, 13 falling below 30 percent of the reported THC and three samples falling below half of the reported THC. Notably, only one sample had slightly higher THC than reported. Four were within the reported range.
The observed disparity was not due to aging. When THC ages and degrades, it turns into cannabinol, or CBN. CBN was not found in measurable amounts in any of the samples, however, and further testing indicated stable THC levels over time.
What still isn’t known
A fundamental query looms large: With advancements in cultivation techniques, including lighting, nutrients and selective breeding, has the potency of cannabis flower genuinely surged over the past 15 years?
THC levels averaged 9.75 percent back in 2009, based on testing of DEA-seized cannabis flower. Today, levels reportedly surpass 35 percent, though they’re not as common as consumers have been led to believe. DEA-seized cannabis flower averaged 13.88 percent in 2019, which is closer to my observed mean of 14.98 percent than the reported mean of my samples, which was 20.27 percent to 24.10 percent.
H/T: marijuanamoment.net
You can view the whole article at this link.